Banca de QUALIFICAÇÃO: ANA KELLY DE ALMEIDA

Uma banca de QUALIFICAÇÃO de DOUTORADO foi cadastrada pelo programa.
DISCENTE : ANA KELLY DE ALMEIDA
DATA : 20/06/2018
HORA: 09:00
LOCAL: Sala de Aula do PPg em Psicobiologia
TÍTULO:

Effects of Somatic Experience therapy on biological markers in male victims of assault with post-traumatic stress disorder (PTSD)


PALAVRAS-CHAVES:

Post-traumatic stress disorder, assault, Somatic Experience ®, steroid hormones, affect, validation questionnaire, DSM-IV, DSM-V.


PÁGINAS: 92
GRANDE ÁREA: Ciências Humanas
ÁREA: Psicologia
RESUMO:

Post-Traumatic Stress Disorder (PTSD) is characterized essentially by the development of symptoms after exposure to one or more traumatic events, and its clinical presentation, which includes psychological, physiological and behavioral components, may vary among the different individuals, since these may exhibit different combinations of symptomatic patterns included in the disease diagnostic criteria (DSM-IV). In the contemporary world, violence in urban centers has increased, with assaults or robberies followed by death. Evidence from studies on the neurobiology of PTSD evidences neural systems particularly involved in their pathology and different types of treatment approaches. For example, there are a number of approaches and therapeutic techniques of a psychological nature including the Somatic ® Experience (SE ™), focused on solving symptoms of chronic stress and posttraumatic stress. In this context, the general objective of this study is to (1) investigate the clinical symptoms and possible biological marker associated with the study of the evolution of PTSD treatment using the SE ™ technique in adult men who were victims of assault in the city of Natal, to validate a structured questionnaire for screening and testing of PTSD symptoms, based on DSM-V, which corresponds to the updated version of this manual, conducted in 2013. sample whose n = 30 participants. The results of the first study showed that 6 of the 14 participants used medication. Plasma concentrations of cortisol varied among individuals, with an increase of 42.9% and a decline of 57.1 in the participants, in relation to the pre-therapy concentrations. Regarding symptom analysis, a significant improvement in positive affect and a statistically significant decrease in negative affect were observed regardless of the use of medication. The improvement in symptoms at follow-up was 85.3%. The complementation of the data collection to be performed in a sample of 30 participants should strengthen or not the current evidence, so that we can conclude that SE ™ is a psychological treatment to be indicated for the treatment of PTSD. Study 2 is in the analysis phase of the data.


MEMBROS DA BANCA:
Externo ao Programa - 009.371.074-76 - EMERSON ARCOVERDE NUNES - UFRN
Presidente - 6346130 - MARIA BERNARDETE CORDEIRO DE SOUSA
Externo à Instituição - PAULA ADRIANA BORBA - UNP
Notícia cadastrada em: 14/06/2018 15:40
SIGAA | Superintendência de Tecnologia da Informação - (84) 3342 2210 | Copyright © 2006-2024 - UFRN - sigaa13-producao.info.ufrn.br.sigaa13-producao